Bill
National Health Amendment (General Co-payment) Bill 2022
passed, as at 2022-11-09. Health and Aged Care portfolio.
- Sponsor
- Not recorded
- Portfolio
- Health and Aged Care
Recorded stages
- introduced — 2022-09-07
- second reading — 2022-09-07
- second reading — 2022-09-27
- second reading — 2022-09-28
- second reading — 2022-09-28
- third reading — 2022-09-28
- introduced — 2022-10-25
- second reading — 2022-10-25
- second reading — 2022-10-26
- committee — 2022-10-26
- third reading — 2022-10-26
- other — 2022-10-27
- other — 2022-10-27
- passed — 2022-10-27
- royal assent — 2022-11-09
Divisions
No divisions recorded. Most questions are decided on the voices; this does not establish that a bill was unopposed.
Plain-language summary
Written by a model from the explanatory memorandum; not the record, as at 2022-09-07.
The bill would cut the standard fee patients pay for subsidised medicines by $12.50, bringing it to $30.00 from 1 January 2023.
Pharmacies could voluntarily reduce the price of some medicines whose cost to the government falls between the new and old patient charges, so that no patient pays more after the cut.
Indexation of the patient charge would restart on 1 January 2024, and the upper price limit for the optional discount would also be indexed annually from 1 January 2023.
- Reduces the Pharmaceutical Benefits Scheme general patient charge from $42.50 to $30.00.
- Allows pharmacists to discount the Commonwealth Price of certain PBS medicines to general patients by more than $1.
- Resumes indexation of the general patient charge from 1 January 2024.
General patients and pharmacists under the Pharmaceutical Benefits Scheme.
Sources
em
billhome
frl act